港股异动 | 药明康德(02359)一度跌近10%领跌CRO概念股去年营收破400亿增长仍靠欧美市场

智通财经03-19

智通财经APP获悉，CRO概念股跌幅靠前，截至发稿，药明康德(02359)跌7.6%，报39.5港元；金斯瑞生物科技(01548)跌5.73%，报15.78港元；康龙化成(03759)跌3.54%，报10.34港元；昭衍新药(06127)跌2.86%，报10.2港元。消息面上，药明康德发布2023年度业绩，收入403.408亿元(人民币，下同)，同比增长2.5%；母公司持有者的应占溢利106.9...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2420250945?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-19 09:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2420250945","market":"hk","top_or_hot":-1,"title":"港股异动 | 药明康德(02359)一度跌近10%领跌CRO概念股 去年营收破400亿 增长仍靠欧美市场","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，CRO概念股跌幅靠前，截至发稿，药明康德(02359)跌7.6%，报39.5港元；金斯瑞生物科技(01548)跌5.73%，报15.78港元；康龙化成(03759)跌3.54%，报10.34港元；昭衍新药(06127)跌2.86%，报10.2港元。消息面上，药明康德发布2023年度业绩，收入403.408亿元(人民币，下同)，同比增长2.5%；母公司持有者的应占溢利106.9...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1088204.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 药明康德(02359)一度跌近10%领跌CRO概念股 去年营收破400亿 增长仍靠欧美市场</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 药明康德(02359)一度跌近10%领跌CRO概念股 去年营收破400亿 增长仍靠欧美市场\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-19 09:50 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1088204.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，CRO概念股跌幅靠前，截至发稿，药明康德(02359)跌7.6%，报39.5港元；金斯瑞生物科技(01548)跌5.73%，报15.78港元；康龙化成(03759)跌3.54%，报10.34港元；昭衍新药(06127)跌2.86%，报10.2港元。消息面上，药明康德发布2023年度业绩，收入403.408亿元(人民币，下同)，同比增长2.5%；母公司持有者的应占溢利106.9...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1088204.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06127","symbol_name":"昭衍新药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1088204.html","article_id":"2420250945","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2420250945","pubTimestamp":1710813040,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"消息面上，药明康德发布2023年度业绩，收入403.408亿元，同比增长2.5%；母公司持有者的应占溢利106.9亿元，同比增长21.3%；拟向全体股东每10股派发现金股息9.8336元(含税)。此外，据药明康德年报透露，公司预计2024年收入达到人民币383亿-405亿元，剔除特定商业化生产项目后将保持正增长。日前BIO在其官网更改原有的新闻内容，并宣布“药明康德已主动终止了其BIO会员资格”。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"06127":"昭衍新药","07226":"XL二南方恒科","02359":"药明康德","YINN":"三倍做多富时中国ETF-Direxion","03759":"康龙化成","01548":"金斯瑞生物科技","YANG":"三倍做空富时中国ETF-Direxion"},"translate_title":"Hong Kong stock change WuXi PharmaTech (02359) once fell by nearly 10%, leading the decline. CRO concept stocks broke through 40 billion revenue last year and still rely on European and American markets","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02359":1,"07226":1,"YANG":1,"YINN":1,"01548":0.9,"03759":0.9,"06127":0.9},"content_text":"智通财经APP获悉，CRO概念股跌幅靠前，截至发稿，药明康德(02359)跌7.6%，报39.5港元；金斯瑞生物科技(01548)跌5.73%，报15.78港元；康龙化成(03759)跌3.54%，报10.34港元；昭衍新药(06127)跌2.86%，报10.2港元。消息面上，药明康德发布2023年度业绩，收入403.408亿元(人民币，下同)，同比增长2.5%；母公司持有者的应占溢利106.9亿元，同比增长21.3%；拟向全体股东每10股派发现金股息9.8336元(含税)。此外，据药明康德年报透露，公司预计2024年收入达到人民币383亿-405亿元，剔除特定商业化生产项目后将保持正增长。值得注意的是，报告期内，药明康德来自美国、欧洲客户收入分别增长42%和12%；而中国业务仅增长1%。在美生物安全法案不断推进和存在不允许与药明康德发生业务往来可能性的情况下，药明康德2024年的业绩或存在不确定性。日前BIO在其官网更改原有的新闻内容，并宣布“药明康德已主动终止了其BIO会员资格”。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2420250945"}

港股异动 | 药明康德(02359)一度跌近10%领跌CRO概念股 去年营收破400亿 增长仍靠欧美市场

精彩评论

港股异动 | 药明康德(02359)一度跌近10%领跌CRO概念股去年营收破400亿增长仍靠欧美市场